The Latest
-
Covid-19 Testing Is Broken and There’s No Plan to Fix It
-
Franco-Nevada Extends Breakout
-
Aurinia Pharma Surges 9% On Priority Review For Lupus Kidney Treatment
-
Texas Instruments Provides Upbeat Sales Outlook; Top Analyst Sees 18% Upside